IRADIMED CORP - Common Stock (IRMD)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
4,699,586
Share change
+198,504
Total reported value
$107,170,220
Price per share
$22.80
Number of holders
53
Value change
+$4,635,505
Number of buys
25
Number of sells
26

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q4 2020

As of 31 Dec 2020, IRADIMED CORP - Common Stock (IRMD) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,699,586 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Nine Ten Capital Management LLC, Russell Investments Group, Ltd., BlackRock Inc., VANGUARD GROUP INC, Soleus Capital Management, L.P., RK Capital Management, LLC, RICE HALL JAMES & ASSOCIATES, LLC, Ranger Investment Management, L.P., and Mondrian Investment Partners LTD. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.